Relapsed/Refractory Follicular Non-Hodgkin Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Follicular Non-Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma (NCT03332017) | BeiGene | 2017-11-14 |
Track Relapsed/Refractory Follicular Non-Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.